Robin Weaver

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

Thomas A. Davis, Antonio J Grillo-López, Christine A. White et al. · Journal of Clinical Oncology · 2000 · 688 citations

Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up

Myron S. Czuczman, Robin Weaver, Baha Alkuzweny et al. · Journal of Clinical Oncology · 2004 · 364 citations · Full text

Single-Agent Monoclonal Antibody Efficacy in Bulky Non-Hodgkin's Lymphoma: Results of a Phase II Trial of Rituximab

Thomas A. Davis, Christine A. White, A.J. Grillo-López et al. · Journal of Clinical Oncology · 1999 · 289 citations

Immunology, Immunotherapy, Hematological Malignancy +16

Prognostic factors for non-Hodgkin's lymphoma patients treated with chemotherapy may not predict outcome in patients treated with rituximab

M. S. Czuczman, A.J. Grillo-López, Baha Alkuzweny et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 26 citations

Prognostic Factors, Immunology, Pathology +16

Reducing Behavior Problems in the Elementary School Classroom. IES Practice Guide. NCEE 2008-012.

Michael H. Epstein, Marc S. Atkins, Douglas Cullinan et al. · 2008 · 25 citations

Teacher Education, Child Psychology, Behavioral Sciences +13